Economic Evaluation of a Novel MicroRNA-Based Assay to Determine Risk of Late Genitourinary Radiation Toxicity in Patients With Prostate Cancer
Jacie T. Cooper, John E. Schneider · 2025
Read Economic Evaluation of a Novel MicroRNA-Based Assay to Determine Risk of Late Genitourinary Radiation Toxicity in Patients With Prostate Cancer by Jacie T. Cooper, John E. Schneider (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12714312.txt.
Description
Jacie Cooper and John Schneider weigh, in a 2025 study, the cash case for a gene test that calls late ray harm in prostate cancer care. Rays cure, yet late water-way harm can last for life, and risk swings by man. No proved tool calls that risk for a man by his own traits. The test, PROSTOX ultra, reads small RNAs to grade risk for a set ray form. With it, plans can steer a man to the ray kind his body bears best. A split tree plus state model frames the sums, for five-year cost and life-long worth.
Cost shifts and life-grade gains from less late harm are the outs. The frame sets what the test must earn to pay its way.
Catalog record
| CREATOR | Jacie T. Cooper, John E. Schneider |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |